tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PSTV Stock Latest News

Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
Press ReleasesPlus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
10h ago
PSTV
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
PremiumPress Releases
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
1d ago
PSTV
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1d ago
ADMA
BCRX
Plus Therapeutics announces up to $18M private placement financing
PremiumThe Fly
Plus Therapeutics announces up to $18M private placement financing
4d ago
PSTV
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
PremiumPress Releases
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
4d ago
PSTV
Plus Therapeutics receives $3M award recommendation from U.S. DOD
PremiumThe FlyPlus Therapeutics receives $3M award recommendation from U.S. DOD
18d ago
PSTV
Is PSTV a Buy, Before Earnings?
PremiumPre-Earnings
Is PSTV a Buy, Before Earnings?
24d ago
PSTV
Plus Therapeutics appoints Andrew Brenner, Barbara Blouw to management team
PremiumThe Fly
Plus Therapeutics appoints Andrew Brenner, Barbara Blouw to management team
1M ago
PSTV
Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team
PremiumPress Releases
Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plus’ Management Team
1M ago
PSTV
Plus Therapeutics announces validation, implementation of CSF-01 diagnostic
PremiumThe Fly
Plus Therapeutics announces validation, implementation of CSF-01 diagnostic
2M ago
PSTV
Plus Therapeutics CEO’s Insightful Presentation Now Available
PremiumCompany Announcements
Plus Therapeutics CEO’s Insightful Presentation Now Available
2M ago
8K
PSTV
Plus Therapeutics completes dosing in Cohort 5 of ReSPECT-LM Phase 1 trial
PremiumThe Fly
Plus Therapeutics completes dosing in Cohort 5 of ReSPECT-LM Phase 1 trial
2M ago
PSTV
Plus Therapeutics Is Worried About This – Should You Be Worried Too?
PremiumCompany AnnouncementsPlus Therapeutics Is Worried About This – Should You Be Worried Too?
2M ago
PSTV
Plus Therapeutics reports FY23 EPS ($4.24) vs ($11.58) last year
PremiumThe Fly
Plus Therapeutics reports FY23 EPS ($4.24) vs ($11.58) last year
2M ago
PSTV
Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
PremiumPress Releases
Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
2M ago
PSTV
PSTV Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PSTV Upcoming Earnings Report: What to Expect?
3M ago
PSTV
Plus Therapeutics expects cash to fund operations to 2H25
PremiumThe Fly
Plus Therapeutics expects cash to fund operations to 2H25
5M ago
PSTV
Plus Updates Financial and Cash Guidance for 2024
PremiumPress Releases
Plus Updates Financial and Cash Guidance for 2024
5M ago
PSTV
Plus Therapeutics partners with K2bio to develop novel tests for CSF analyses
PremiumThe Fly
Plus Therapeutics partners with K2bio to develop novel tests for CSF analyses
5M ago
PSTV
Plus Therapeutics files to sell common stock, warrants, no amount given
PremiumThe FlyPlus Therapeutics files to sell common stock, warrants, no amount given
6M ago
PSTV
Plus Therapeutics reports interim ReSPECT-GBM Phase 2 trial data
PremiumThe Fly
Plus Therapeutics reports interim ReSPECT-GBM Phase 2 trial data
6M ago
PSTV
Plus Therapeutics to Host Virtual KOL Event on New Phase 2 ReSPECT-GBM Data in Recurrent Glioblastoma Presented at the Society for NeuroOncology (SNO) Conference on Monday, November 20, 2023
PremiumPress Releases
Plus Therapeutics to Host Virtual KOL Event on New Phase 2 ReSPECT-GBM Data in Recurrent Glioblastoma Presented at the Society for NeuroOncology (SNO) Conference on Monday, November 20, 2023
6M ago
PSTV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >